| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 流感疫苗(元) | 58,827,704.89 | 1,072,997,826.90 | 11,207,481.69 | 2,402,643,148.24 | 148,147,883.90 |
| 狂犬疫苗(元) | - | - | 21,333,922.35 | - | - |
| 其他疫苗(元) | - | - | - | - | 860,263.32 |
| 其他(元) | 1,134,069.38 | 54,814,496.95 | - | 7,785,308.96 | - |
| 营业成本(元) | |||||
| 流感疫苗(元) | 13,718,389.27 | 194,802,851.54 | 283,236.58 | 281,332,927.75 | -2,983,410.35 |
| 狂犬疫苗(元) | - | - | 5,191,182.03 | - | - |
| 其他疫苗(元) | - | - | - | - | 1,023,683.33 |
| 其他(元) | 1,118,816.43 | 17,755,936.59 | - | 5,764,813.49 | - |
| 毛利(元) | |||||
| 流感疫苗(元) | 45,109,315.62 | 878,194,975.36 | 10,924,245.11 | 2,121,310,220.49 | 151,131,294.25 |
| 狂犬疫苗(元) | - | - | 16,142,740.32 | - | - |
| 其他疫苗(元) | - | - | - | - | -163,420.01 |
| 其他(元) | 15,252.95 | 37,058,560.36 | - | 2,020,495.47 | - |
| 毛利率(%) | |||||
| 流感疫苗(%) | 76.68 | 81.84 | 97.47 | 88.29 | 102.01 |
| 狂犬疫苗(%) | - | - | 75.67 | - | - |
| 其他疫苗(%) | - | - | - | - | -19.00 |
| 其他(%) | 1.34 | 67.61 | - | 25.95 | - |
| 收入构成(%) | |||||
| 流感疫苗(%) | 98.11 | 95.14 | 34.44 | 99.68 | 99.42 |
| 狂犬疫苗(%) | - | - | 65.56 | - | - |
| 其他疫苗(%) | - | - | - | - | 0.58 |
| 其他(%) | 1.89 | 4.86 | - | 0.32 | - |
| 毛利构成(%) | |||||
| 流感疫苗(%) | 99.97 | 95.95 | 40.36 | 99.90 | 100.11 |
| 狂犬疫苗(%) | - | - | 59.64 | - | - |
| 其他疫苗(%) | - | - | - | - | -0.11 |
| 其他(%) | 0.03 | 4.05 | - | 0.10 | - |